SCHEMBL17170776

SCHEMBL17170776

c1ccc(N2c3ccccc3N(c3ccc(-n4c5ccccc5c5cc6c(cc54)Oc4ccccc4O6)cc3)c3ccccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ ATM Q13315 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPK8 P45983 2/20 0.35
▸ MAPK9 P45984 1/20 0.35
▸ EDNRA P25101 2/20 0.34
▸ EDNRB P24530 1/20 0.34
▸ HDAC4 P56524 1/20 0.33
▸ PGR P06401 2/20 0.33
▸ KDR P35968 1/20 0.33
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ TSHR P16473 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ POLB P06746 1/20 0.32
▸ BRCA1 P38398 1/20 0.32
▸ PTPN1 P18031 2/20 0.32
▸ P2RX4 Q99571 1/20 0.31
▸ HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17170791 0.93 KDM4E (0.42) KDM4EL3MBTL1ATMALDH1A1MAPK8
SCHEMBL17170775 0.89 L3MBTL1 (0.55) KDM4EL3MBTL1ATMALDH1A1MAPK8
SCHEMBL17170363 0.89 L3MBTL1 (0.55) KDM4EL3MBTL1ATMALDH1A1MAPK8
SCHEMBL17170781 0.87 HDAC6 (0.38) KDM4EL3MBTL1ATMALDH1A1
SCHEMBL18969182 0.84 L3MBTL1 (0.47) KDM4EL3MBTL1ATMALDH1A1MAPK8
SCHEMBL15470147 0.84 L3MBTL1 (0.46) KDM4EL3MBTL1ATMALDH1A1MAPK8
SCHEMBL23936688 0.84 L3MBTL1 (0.43) KDM4EL3MBTL1ATMALDH1A1EDNRA
SCHEMBL17170369 0.83 KDM4E (0.48) KDM4EL3MBTL1ATMALDH1A1MAPK8
SCHEMBL17170375 0.82 KDM4E (0.47) KDM4EL3MBTL1ATMALDH1A1MAPK8
SCHEMBL22965024 0.82 L3MBTL1 (0.72) KDM4EL3MBTL1ATMALDH1A1MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same DOOSAN SOLUS CO., LTD. (KR) 2020-08-25 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
WO-2015156580-A2 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 주식회사 두산 2015-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OR10J3, ORC3, L1CAM KDM4E 909/4885L3MBTL1 609/4885ATM 1000/4885
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same OR10J3, L1CAM, ICOSLG KDM4E 953/4885L3MBTL1 314/4885ATM 1280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback